Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis - PubMed (original) (raw)
Review
. 2016 Jun 28;10(4):959-66.
doi: 10.1177/1932296816633721. Print 2016 Jul.
Julián Esteban Barahona-Correa 1, Diana Marcela Romero-Alvernia 1, Sebastián Gil-Tamayo 1, Camilo Castañeda-Cardona 2, Juan Gabriel Bayona 1, Juan José Triana 1, Andrés Felipe Laserna 1, Miguel Mejía-Torres 1, Paula Restrepo-Jimenez 1, Juliana Jimenez-Zapata 1, Diego Rosselli 3
Affiliations
- PMID: 26920639
- PMCID: PMC4928229
- DOI: 10.1177/1932296816633721
Review
Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis
Pieralessandro Lasalvia et al. J Diabetes Sci Technol. 2016.
Abstract
Objectives: Pen devices offer advantages compared with vial and syringe (VaS). The purpose of this article was to evaluate efficacy of pen devices compared to VaS.
Methods: A systematic review of literature was performed in 8 different databases. References were independently screened and selected. Primary observational or experimental studies comparing pen devices with VaS for insulin administrations were included. Studies on specific populations were excluded. Risk of bias was evaluated using appropriate tools. Data on glycosylated hemoglobin (HbA1c), hypoglycemia, adherence, persistence, patient preference, and quality of life (QOL) were collected. Meta-analysis was performed when appropriate. Heterogeneity and risk of publication bias were evaluated. Otherwise, descriptive analyses of the available data was done.
Results: In all, 10 348 articles were screened. A total of 17 studies were finally selected: 7 experimental and 10 analytical. The populations of the included articles were mainly composed of adults with type 2 diabetes mellitus. Important risk of bias was found in all of the articles, particularly experimental studies. Meta-analyses were performed for HbA1c, hypoglycemia, adherence and persistence. Pen device showed better results in mean HbA1c change, patients with hypoglycemia, adherence and persistence compared to VaS. No difference was observed in number of patients achieving <7% HbA1c. Preference studies showed a tendency favoring pen devices, however nonvalidated tools were used. One QoL study showed improvements in some subscales of SF-36.
Conclusions: There is evidence that pen devices offer benefits in clinical and, less clearly, patient-reported outcomes compared to VaS for insulin administration. However, these results should be taken with caution.
Keywords: diabetes mellitus; equipment and supplies; glycosylated; hemoglobin A; insulin; medication adherence; patient preference.
© 2016 Diabetes Technology Society.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Figure 1.
Flow chart or literature search and article selection.
Figure 2.
Forest plots of meta-analysis for the comparisons between pen devices and vial and syringe (VaS). (A) Percentage of patients achieving HbA1c<7% at 12 months. (B) Mean hBA1c change at 12 months. (C) Mean HbA1c change at 12 months, only studies with insulin-naïve patients. (D) Percentage of patients suffering at least 1 episode of hypoglycemia after 12 months. (E) Mean change for medication possession ratio (MPR) after 12 months. (F) Percentage of persistent patients after 12 months.
Similar articles
- Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH, Lim SH, Huang MC, Bee YM, Wee HL. Cheen HH, et al. Clin Ther. 2014 Jul 1;36(7):1043-53. doi: 10.1016/j.clinthera.2014.05.009. Epub 2014 Jun 7. Clin Ther. 2014. PMID: 24913030 - Overview of insulin delivery pen devices.
Kroon L. Kroon L. J Am Pharm Assoc (2003). 2009 Sep-Oct;49(5):e118-31. doi: 10.1331/JAPhA.2009.08125. J Am Pharm Assoc (2003). 2009. PMID: 19692314 Review. - What can we learn from patient-reported outcomes of insulin pen devices?
Anderson BJ, Redondo MJ. Anderson BJ, et al. J Diabetes Sci Technol. 2011 Nov 1;5(6):1563-71. doi: 10.1177/193229681100500633. J Diabetes Sci Technol. 2011. PMID: 22226279 Free PMC article. Review.
Cited by
- 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.
Moon JS, Kang S, Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Seo JA, Kim MK, Lim JH, Song YJ, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Bae J, Jeon E, Kim JM, Kang SM, Park JH, Yun JS, Cha BS, Moon MK, Lee BW. Moon JS, et al. Diabetes Metab J. 2024 Jul;48(4):546-708. doi: 10.4093/dmj.2024.0249. Epub 2024 Jul 26. Diabetes Metab J. 2024. PMID: 39091005 Free PMC article. No abstract available. - 7. Diabetes Technology: Standards of Care in Diabetes-2024.
American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007. Diabetes Care. 2024. PMID: 38078575 Review. - 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association.
Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Kim NH, Seo JA, Kim MK, Lim JH, Song Y, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Choi WS, Moon MK. Choi JH, et al. Diabetes Metab J. 2023 Sep;47(5):575-594. doi: 10.4093/dmj.2023.0282. Epub 2023 Sep 26. Diabetes Metab J. 2023. PMID: 37793979 Free PMC article. Review. - The Evolution of Insulin Administration in Type 1 Diabetes.
Pinnaro CT, Tansey MJ. Pinnaro CT, et al. J Diabetes Mellitus. 2021 Nov;11(5):249-277. doi: 10.4236/jdm.2021.115021. Epub 2021 Nov 17. J Diabetes Mellitus. 2021. PMID: 37745178 Free PMC article. - Analysis of Nurse and Patient Preferences for Pre-Filled Pen Devices for Self-Injection of Highly Purified Human Menopausal Gonadotropin (HP-hMG, MENOPUR®).
De Mesmaeker G, Calles B, Smith JA. De Mesmaeker G, et al. Patient Prefer Adherence. 2023 May 17;17:1281-1292. doi: 10.2147/PPA.S385247. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37220565 Free PMC article.
References
- Díaz M, Peña E, Mejía A, Flórez I. Manual metodológico para la elaboración de evaluaciones de efectividad, seguridad y validez diagnóstica de tecnologías en salud- IETS. 2014.
- Higgins J, Green S. Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions. 2011. Available at: http://handbook.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_inclu....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical